Skip to main content

Ultragenyx Pharmaceutical Inc.

RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001515673

In the last 90 days, Ultragenyx Pharmaceutical Inc. insiders filed 0 open-market purchases and 5 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $3.55B in total; no superinvestor holds it.

13F holders, Q2 2025

Institutional positions in Ultragenyx Pharmaceutical Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
311
+11 vs. Q1 2025
Shares held
94.1M
+4.32M (+4.8%) vs. Q1 2025
Total value
$3.42B
+$169.1M (+5.2%) vs. Q1 2025
New holders
54
117 more added
Sold out
43
108 more reduced

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RARE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 311 institutions
Q1 2021: 255 institutionsQ2 2021: 242 institutionsQ3 2021: 223 institutionsQ4 2021: 235 institutionsQ1 2022: 240 institutionsQ2 2022: 225 institutionsQ3 2022: 233 institutionsQ4 2022: 228 institutionsQ1 2023: 230 institutionsQ2 2023: 243 institutionsQ3 2023: 221 institutionsQ4 2023: 237 institutionsQ1 2024: 270 institutionsQ2 2024: 275 institutionsQ3 2024: 302 institutionsQ4 2024: 314 institutionsQ1 2025: 301 institutionsQ2 2025: 311 institutionsQ3 2025: 303 institutionsQ4 2025: 288 institutionsQ1 2026: 298 institutionsQ2 2026: 311 institutions
Value heldQ2 2025: $3.42B
Q1 2021: $7.73BQ2 2021: $6.24BQ3 2021: $6.01BQ4 2021: $5.69BQ1 2022: $4.87BQ2 2022: $4.03BQ3 2022: $2.81BQ4 2022: $3.15BQ1 2023: $2.76BQ2 2023: $3.21BQ3 2023: $2.52BQ4 2023: $3.84BQ1 2024: $3.73BQ2 2024: $3.63BQ3 2024: $4.83BQ4 2024: $3.68BQ1 2025: $3.25BQ2 2025: $3.42BQ3 2025: $2.87BQ4 2025: $2.16BQ1 2026: $2.05BQ2 2026: $3.55B
Institutions holding RARE and their total value by quarter
QuarterHoldersValue
Q2 2026311$3.55B
Q1 2026298$2.05B
Q4 2025288$2.16B
Q3 2025303$2.87B
Q2 2025311$3.42B
Q1 2025301$3.25B
Q4 2024314$3.68B
Q3 2024302$4.83B
Q2 2024275$3.63B
Q1 2024270$3.73B
Q4 2023237$3.84B
Q3 2023221$2.52B
Q2 2023243$3.21B
Q1 2023230$2.76B
Q4 2022228$3.15B
Q3 2022233$2.81B
Q2 2022225$4.03B
Q1 2022240$4.87B
Q4 2021235$5.69B
Q3 2021223$6.01B
Q2 2021242$6.24B
Q1 2021255$7.73B

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding Ultragenyx Pharmaceutical Inc.; share changes are against Q1 2025.

Institutions holding RARE in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Federated Hermes, Inc.2,049,501$74.5M0.14%−5,699−0.3%Reduced
Clearbridge Investments, LLC2,140,577$77.8M0.06%−119,128−5.3%Reduced
Suvretta Capital Management, LLC2,278,000$82.8M3.12%+253,500+12.5%Added
State Street Corp2,572,240$93.5M0.00%−46,250−1.8%Reduced
FMR LLC2,604,588$94.7M0.01%+2,223,166+582.9%Added
Baker Bros. Advisors LP2,772,692$100.8M0.98%+1,196,578+75.9%Added
Price T Rowe Associates Inc2,886,268$104.9M0.01%−332,674−10.3%Reduced
JPMorgan Chase & Co3,260,868$118.6M0.01%+2,951,397+953.7%Added
Sands Capital Management, LLC3,943,485$143.4M0.41%−220,076−5.3%Reduced
BlackRock, Inc.6,256,145$227.5M0.00%+97,879+1.6%Added
Vanguard Group Inc10,213,422$371.4M0.01%+217,196+2.2%Added
Vestal Point Capital, LP0$00.00%−500,000−100.0%Sold out
Cutter Capital Management, LP0$00.00%−379,303−100.0%Sold out
SG Americas Securities, LLC0$00.00%−237,573−100.0%Sold out
Ikarian Capital, LLC0$00.00%−216,989−100.0%Sold out
Granite Investment Partners, LLC0$00.00%−216,883−100.0%Sold out
Principal Financial Group Inc0$00.00%−88,068−100.0%Sold out
Duquesne Family Office LLCSuperinvestorDuquesne Family Office0$00.00%−85,445−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−43,274−100.0%Sold out
NFJ Investment Group, LLC0$00.00%−37,667−100.0%Sold out
Simplex Trading, LLC0$00.00%−23,991−100.0%Sold out
SummitTX Capital, L.P.0$00.00%−20,085−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−13,783−100.0%Sold out
HighVista Strategies LLC0$00.00%−13,328−100.0%Sold out
Intech Investment Management LLC0$00.00%−12,839−100.0%Sold out
Inceptionr LLC0$00.00%−12,803−100.0%Sold out
Axq Capital, LP0$00.00%−12,346−100.0%Sold out
Magnetar Financial LLC0$00.00%−11,147−100.0%Sold out
Bayforest Capital Ltd0$00.00%−9,190−100.0%Sold out
Oxford Asset Management LLP0$00.00%−8,421−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−7,991−100.0%Sold out
Dimensional Fund Advisors LP0$00.00%−7,764−100.0%Sold out
Teza Capital Management LLC0$00.00%−5,941−100.0%Sold out
SIH Partners, LLLP0$00.00%−5,738−100.0%Sold out
Stephenson National Bank & Trust0$00.00%−2,386−100.0%Sold out
Corebridge Financial, Inc.0$00.00%−1,577−100.0%Sold out
Antipodes Partners Ltd0$00.00%−1,568−100.0%Sold out
Ci Investments Inc.0$00.00%−1,330−100.0%Sold out
Coldstream Capital Management Inc0$00.00%−923−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−298−100.0%Sold out
Clear Street Markets LLC0$00.00%−192−100.0%Sold out
Quent Capital, LLC0$00.00%−183−100.0%Sold out
Boston Private Wealth LLC0$00.00%−139−100.0%Sold out
CIBC Private Wealth Group, LLC0$00.00%−43−100.0%Sold out
Bokf, NA0$00.00%−34−100.0%Sold out
Sierra Ocean, LLC0$00.00%−29−100.0%Sold out
Picton Mahoney Asset Management0$00.00%−50−100.0%Sold out
South State Corp.0$00.00%−25−100.0%Sold out
Hexagon Capital Partners LLC0$00.00%−19−100.0%Sold out
Signature Resources Capital Management, LLC0$00.00%−14−100.0%Sold out
Whipplewood Advisors, LLC0$00.00%−7−100.0%Sold out
Principal Securities, Inc.0$00.00%−7−100.0%Sold out
Clearstead Advisors, LLC0$00.00%−5−100.0%Sold out
True Wealth Design, LLC0$00.00%−5−100.0%Sold out
Lindbrook Capital, LLC––––Not filed